Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1595888 NEW YORK, NY
Back to ACHV Full portfolio

Position in ACHV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$329,476
-$189,727 QoQ
Shares Held
50,456
-71.4% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 111 holders
Holding Since
Sep 2022
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Derivatives in ACHV

reported options exposure · as of Jun 30, 2026
CallValue
$1,331,467
CallShares
203,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. ACHV ranks #144 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in ACHV

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $329,476 50,456
2026-06-30 $1,331,467 203,900
2026-03-31 $519,203 176,600
2025-12-31 $67,592 13,600
2025-12-31 $1,899,587 382,211
2025-09-30 $235,935 74,900
2025-06-30 $159,219 70,452
2024-09-30 $70,583 14,891
2022-09-30 $53,070 16,082